Literature DB >> 2807884

Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines.

R R Weichselbaum1, E J Dunphy, M A Beckett, A G Tybor, W J Moran, M E Goldman, E E Vokes, W R Panje.   

Abstract

We studied epidermal growth factor receptor (EGFR) gene amplification and expression in 11 early passage human head and neck carcinoma cell lines. Three cell lines demonstrated EGFR gene amplification and 10 lines showed an increase in EGFR mRNA when compared with normal keratinocytes, placenta, and a human skin carcinoma cell line. The effects of EGF on growth in 6 head and neck carcinoma cell lines was also studied. Growth inhibition at a concentration of 20 ng/mL was observed in one cell line but had no effect on growth in 5 cell lines. An increase in EGFR may be important in the etiology of, or progression of, head and neck carcinoma although the mechanisms need to be elucidated by further study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807884     DOI: 10.1002/hed.2880110510

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

Review 1.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

2.  Epidermal growth factor receptors in the oesophagus.

Authors:  J Jankowski; S Murphy; G Coghill; A Grant; K G Wormsley; D S Sanders; M Kerr; D Hopwood
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Selective Inhibition of STAT3 Phosphorylation Using a Nuclear-Targeted Kinase Inhibitor.

Authors:  Matthew D Bartolowits; Wells Brown; Remah Ali; Anthony M Pedley; Qingshou Chen; Kyle E Harvey; Michael K Wendt; Vincent Jo Davisson
Journal:  ACS Chem Biol       Date:  2017-08-18       Impact factor: 5.100

4.  Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.

Authors:  Flonia Levy-Adam; Sari Feld; Victoria Cohen-Kaplan; Anna Shteingauz; Miriam Gross; Gil Arvatz; Inna Naroditsky; Neta Ilan; Ilana Doweck; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

5.  Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer.

Authors:  Victoria Cohen-Kaplan; Jenny Jrbashyan; Yoav Yanir; Inna Naroditsky; Ofer Ben-Izhak; Neta Ilan; Ilana Doweck; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

Review 6.  Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.

Authors:  Toni M Brand; Mari Iida; Deric L Wheeler
Journal:  Cancer Biol Ther       Date:  2011-05-01       Impact factor: 4.742

Review 7.  The nature of the head and neck cancer.

Authors:  A G Maran; J A Wilson; M N Gaze
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma.

Authors:  Katie Ridd; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2009-10-08       Impact factor: 8.551

9.  erbB-3, a third member of the erbB/epidermal growth factor receptor gene family: its expression in head and neck cancer cell lines.

Authors:  W J Issing; W J Heppt; E R Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.

Authors:  Hannah E Pearson; Mari Iida; Rachel A Orbuch; Nellie K McDaniel; Kwangok P Nickel; Randall J Kimple; Jack L Arbiser; Deric L Wheeler
Journal:  Mol Cancer Ther       Date:  2017-10-20       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.